MUNICH, Germany—Dropping aspirin after 1 month and continuing monotherapy with ticagrelor is no better than standard dual antiplatelet therapy (aspirin plus ticagrelor or clopidogrel) among patients ...
Please provide your email address to receive an email when new articles are posted on . Use of a filter-based distal protection device reduced the incidence of the no-reflow phenomenon and was ...
The use of an intracoronary hemodynamic technique, such as FRACTIONAL FLOW RESERVE (FFR), to determine the severity of a stenosis, can help when deciding whether to perform percutaneous coronary ...
AWANS, Belgium -- Miracor Medical SA (Miracor Medical) today announced the initiation and first patient enrollment in the PICSO-AMI-I study to evaluate the benefits of PiCSO® therapy compared with ...
ORLANDO – November 4, 2021 – The FAVOR III China trial found that lesion selection for percutaneous coronary intervention (PCI) using the non-invasively assessed physiologic measurement quantitative ...
Primary percutaneous coronary intervention (PCI) is the standard treatment for ST-segment elevation myocardial infarction (STEMI). Although PCI is effective at opening the infarct-related artery, ...